Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Foc ...
A panel of experts representing the European Commission, industry, and notified bodies reviewed the state discussed the ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Euro Roundup: EMA officials argue against making single pivotal trials the ‘rigid, default position’
Emer Cooke and other EMA leaders have weighed into the debate about whether sponsors should run one or two pivotal trials, arguing that the decision should be informed by the evidence needed to show a ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Experts in medical device and pharmaceutical regulatory affairs discussed how the field has evolved over the last five ...
The European Medicines Agency (EMA) has published a guideline on evaluating drug interactions in the gastrointestinal tract ...
The US Food and Drug Administration (FDA) announced on Tuesday the launch of a pilot program designed to expedite the review ...
This week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
CHARLOTTE, NC — When former US Food and Drug Administration (FDA) Commissioner Robert Califf was a medical student in the mid-1970s, he had an opportunity to work with his mentor on one of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results